A new pill, enlicitide, reduced LDL (“bad”) cholesterol by about 60% in a large clinical trial, matching the power of injectable therapies. Because it’s taken orally, it could overcome one of the biggest barriers keeping patients from using current treatments…
A new experimental pill called enlicitide dramatically lowered levels of low-density lipoprotein (LDL) cholesterol, often referred to as "bad" cholesterol, by as much as 60%, according to a phase thr… [+5281 chars]
